Rhodiola rosea
Also called roseroot, king's-crown, hong jing tian, Arctic root. Herbal extract (root and rhizome), studied as an adaptogen.
Bottom line
Rhodiola rosea is promoted for energy and stress [26]. Early placebo-controlled trials reported less mental fatigue [3][4][5], but a registered trial in nursing students found worse fatigue (its authors urge caution) [6], and a review rated every trial at high or unclear risk of bias [1]. Endurance results are mixed [11][12]. A small study found it modestly slowed CYP2C9 [18].
- A 2012 systematic review found three of five mental-fatigue trials reported a benefit, but rated every included study at high or unclear risk of bias [1].
- In a registered 42-day trial in 48 nursing students on shift work, fatigue worsened with rhodiola compared with placebo; the authors say the result needs careful interpretation [6].
- A 2025 meta-analysis of 26 trials found small endurance gains, while a 2026 meta-analysis of 9 trials across Rhodiola species found no significant effect on VO2max [11][12].
- The only randomized trial of self-reported stress in non-clinical adults we found used a no-treatment control instead of a placebo and was funded by Dr Willmar Schwabe GmbH & Co. KG [8].
- In 13 healthy volunteers, 14 days of a rhodiola product lowered a marker of CYP2C9 enzyme activity by 21%, which the authors say might matter for medicines with a narrow safe range [18].
New to Rhodiola rosea? Start with What is Rhodiola rosea? A plain-English guide.
Evidence by outcome
| Outcome | Grade | Basis | Modifiers | Rationale |
|---|---|---|---|---|
| Endurance performance | B Moderate | A meta-analysis with high heterogeneity (26 RCTs); A not met because direction is inconsistent (a 2026 meta-analysis found no VO2max effect; two null trials) | Why B grade for Endurance performance: explainedApproved of the Endurance performance grade | |
| Perceived stress | C Limited | Open-label or non-placebo-controlled studies only; placebo-controlled data only in a clinical population | Subjective outcome only | Why C grade for Perceived stress: explainedApproved of the Perceived stress grade |
| Mental fatigue | C Limited | >=2 RCTs with mostly consistent results, including one RCT with n >= 100 (161 cadets); A not met: no meta-analysis, and all included trials at high or unclear risk of bias | Single research groupShort-term only | Why C grade for Mental fatigue: explainedApproved of the Mental fatigue grade |
Grades describe evidence for each outcome, not a recommendation. Open a grade for its rationale and dated grade history. How we grade
Below are our grades for mental fatigue, perceived stress and endurance. Our how we grade evidence page explains each grade, and the evidence matrix compares compounds.
Two systematic reviews set the scene. A 2011 review of 11 placebo-controlled randomized controlled trials found that rhodiola may have beneficial effects on physical and mental performance, but noted a lack of independent replication of the individual studies [2]. Only 5 of the 10 trials it scored reached more than three points on the Jadad quality score [2]. The US National Center for Complementary and Integrative Health (NCCIH) says most of the research in people is of low-to-moderate quality [26].
Does rhodiola reduce mental fatigue?
Evidence is mixed: older trials of one extract reported less mental fatigue [3][4][5], while a later registered trial found the opposite [6]. A 2012 systematic review included 11 controlled trials and found that three of five randomized trials of mental fatigue reported a benefit [1]. The same review found that every included study had a high risk of bias or reporting flaws that made its validity hard to judge, and it called the research contradictory [1]. For context, see our hub on mental energy and fatigue.
The positive trials all tested the SHR-5 extract against placebo. In a double-blind crossover trial in 56 young, healthy physicians on night duty, scores on mental fatigue tests improved with one tablet a day, with a statistically significant improvement reported during the first two-week period [3]. In a small randomized, double-blind pilot trial, foreign students in an examination period took the extract or placebo for 20 days; the most significant improvements were in physical fitness, mental fatigue and neuro-motor tests, and the authors thought the dose was probably too low [4]. In 161 military cadets aged 19 to 21, a single dose raised an anti-fatigue index compared with placebo, with no significant difference between the two doses tested [5].
These three trials share a co-author and use the same extract [3][4][5], and the 2011 review flagged the lack of independent replication [2]. Their funding is not stated in the PubMed records we checked.
The main counterweight is a registered trial (NCT01278992) from a different research group, funded by the Government of Alberta through AVAC Ltd. [6]. Forty-eight nursing students on shift work took 364 mg of rhodiola or an identical placebo daily for 42 days [6]. Fatigue worsened with rhodiola compared with placebo on both fatigue measures, though the authors advise caution in reading the result [6].
Two further studies were in people with a diagnosed fatigue syndrome or long-lasting fatigue symptoms, and results may not apply to healthy adults. In a randomized, double-blind trial of 60 adults meeting Swedish diagnostic criteria for fatigue syndrome (a clinical population), both groups improved, showing a placebo effect, but 576 mg a day of SHR-5 for 28 days improved a burnout scale and some attention measures more than placebo [7]. An uncontrolled, open-label study of 100 adults with prolonged or chronic fatigue, who took 2 x 200 mg of WS 1375 for 8 weeks, reported the greatest change after 1 week; the authors describe the analysis as exploratory and meant to generate hypotheses [10].
Does rhodiola lower perceived stress?
The evidence is thin and lacks placebo controls. As of November 11, 2026 we found no placebo-controlled trial of rhodiola alone that measured perceived stress in healthy adults (PubMed and Europe PMC search, November 11, 2026). For related compounds, see our hub on mood and stress.
In a trial funded by Dr Willmar Schwabe GmbH & Co. KG, 80 mildly anxious adults were randomized to 2 x 200 mg a day of the branded product Vitano or to no treatment [8]. The rhodiola group reported less stress and better total mood than the untreated controls at 14 days, with no relevant difference in cognitive test performance [8]. The authors note that it was not placebo-controlled and say they cannot determine a causal relationship [8].
A single-arm, open-label study gave 200 mg of WS 1375 twice daily for 4 weeks to 101 adults with life-stress symptoms [9]. Every questionnaire, including the Perceived Stress Questionnaire, improved, but the study had no comparison group [9]. Its funding is not stated in the PubMed record.
EMA's herbal committee also considered small placebo-controlled studies in adults with stress and fatigue. It observed a possible effect but identified several shortcomings in them, so its conclusions rest on long-standing use instead [22].
Does rhodiola improve endurance?
Evidence is mixed, and the two most recent meta-analyses disagree [11][12]. A 2025 meta-analysis of 26 randomized controlled trials in 668 healthy participants (mean age 22.0) found rhodiola improved VO2max, the body's maximum oxygen uptake (11 studies; effect size, a standardized measure of the difference between groups, 0.32), time to exhaustion (7 studies; 0.38) and time-trial performance (5 studies; -0.40), all small effects compared with placebo or control [11]. Its authors say differences between studies (heterogeneity) warrant cautious interpretation, and some variability persisted after subgroup analyses [11]. VO2max improved more at doses above 600 mg a day in a subgroup analysis [11].
A 2026 meta-analysis of 9 randomized trials (424 healthy adults) found no significant effect on VO2max (95% CI: -0.91 to 2.99; P=0.30) [12]. It pooled several Rhodiola species, including Rhodiola crenulata, and its authors attribute the uncertainty to differences in study design, sample size, dosing and duration [12]. A 2023 systematic review of 13 trials (263 participants) concluded that single doses helped endurance and perceived exertion, while repeated daily use helped anaerobic performance but not endurance, and most included studies had unclear or high risk of bias [13]. See our physical performance hub for other compounds.
Individual trials show the same split. In a randomized, double-blind crossover trial in 24 young healthy volunteers, 200 mg of extract taken 1 hour before testing extended time to exhaustion from 16.8 to 17.2 minutes compared with placebo, but in a 12-person 4-week phase, daily use changed none of the measures [14]. In a double-blind crossover trial in 18 adults, 3 mg/kg taken 1 hour before a 6-mile cycling time trial produced a finish of 25.4 minutes against 25.8 minutes with a carbohydrate placebo, with lower perceived exertion [15]. In contrast, in a randomized trial in 12 resistance-trained men, 1500 mg a day for 4 days produced no significant difference in time to exhaustion [16], and in a double-blind trial in 26 physically active male students, 600 mg a day for 4 weeks did not change endurance capacity, though it shortened reaction time [17].
What the evidence does not show
NCCIH concludes that there isn't enough reliable evidence to determine whether rhodiola is useful for any health-related purpose [26]. Participants in the 2025 endurance meta-analysis had a mean age of 22.0 [11], and men outnumbered women in the 2023 review by 198 to 65 [13], so results may not transfer to women or older adults.
Doses used in studies
Ranges researchers used, not dosing advice. Bars share one scale. Read our disclaimer.
Timing and form
As of November 11, 2026 we found no human pharmacokinetic studies reporting the half-life of rhodiola constituents (PubMed and Europe PMC search, November 11, 2026), so this page cannot report a half-life. In the single-dose endurance trials, participants took the extract 1 hour before testing [14][15]. A systematic review found effects on endurance after single doses but not after repeated daily use [13].
EMA's monograph covers a dry extract made with 67-70% ethanol [21]. In the UK, registered products include capsules with 153 mg of extract and tablets with 200 mg of the WS 1375 extract [24]. Health Canada requires the label direction "Avoid taking before bedtime" on products made under its monograph [23].
What it is
Rhodiola rosea is a plant that grows in cold regions and at high altitudes in Europe, Asia and North America [26], and the part used in supplements and herbal medicines is the dried root and rhizome [23]. Its common names include roseroot, king's-crown and hong jing tian [23], and the European Medicines Agency (EMA) calls it Arctic root [21]. Traditionally it was used for work performance, endurance, fatigue and altitude sickness, among other purposes [26]. Researchers have studied it because of its "purported adaptogenic properties" [1], and today it is promoted for athletic performance, energy and reducing stress [26].
It comes as tablets, capsules and liquid extracts [27]. Health Canada's monograph describes standardized extracts by their content of two marker compounds, 0.8-3% salidroside and 1-6% rosavins [23]. Several trials on this page tested branded extracts: SHR-5 [3][4][5][7] and WS 1375 [9][10].
How it might work (mechanism, not evidence of effect): a 2010 review lists proposed mechanisms that include effects on the hypothalamic-pituitary-adrenal (HPA) stress-hormone system and on defense proteins such as heat shock proteins [20]. Memorial Sloan Kettering's herb database notes that data in humans are limited [27].
Safety and interactions
Safety flag. Systematic reviews report few, mild adverse events, and a 2025 meta-analysis notes that underreporting cannot be ruled out [2][11]. EMA lists headache, nausea, abdominal pain, diarrhea, skin rash and itching as undesirable effects, frequency not known [21]. EMA does not recommend use in pregnancy, breastfeeding or under 18; Health Canada's monograph contraindicates use in bipolar disorder [21][23].
Who sources say should be careful.
- Pregnancy and breastfeeding: EMA does not recommend use because data are insufficient [21], Health Canada requires a label caution to ask a practitioner first [23], and NCCIH says little is known about safety [26]. As of November 11, 2026 we found no human studies of rhodiola in pregnancy or breastfeeding (PubMed and Europe PMC search, November 11, 2026).
- Children and teenagers: EMA does not recommend use under 18 [21], and Health Canada's monograph covers adults 18 years and older [23].
- People with bipolar disorder: Health Canada's monograph states "Do not use if you have bipolar disorder or bipolar spectrum disorder" [23].
- People taking medicines: see the cautions above for medicines broken down by CYP2C9, such as warfarin or phenytoin [18], and for antidepressants, hormone replacement therapy and birth control medication [23].
- People with hypersensitivity to the extract: EMA lists this as a contraindication [21].
- Longer use: EMA's summary says Arctic root medicines should only be used in adults over 18 and not for longer than two weeks without seeking medical advice [22].
A 2011 systematic review of randomized trials found only a few mild adverse events [2], and a 2025 meta-analysis of 26 endurance trials found none reported, though it notes that underreporting cannot be ruled out [11]. In the 42-day nursing trial, the total number of adverse events did not differ between rhodiola and placebo [6]. No serious side effects attributable to the extract were reported in the fatigue syndrome trial [7], and adverse events in the 101-person open-label study were mostly mild, with none serious [9].
EMA lists headache, nausea, abdominal pain, diarrhea, skin rash and itching as undesirable effects, with frequency not known [21]. NCCIH says rhodiola is possibly safe for up to 12 weeks, with side effects that may include dizziness, headache, insomnia, and dry mouth or excessive saliva [26], and Memorial Sloan Kettering lists dizziness and dry mouth [27]. Health Canada requires products under its monograph to tell users: "Stop use if you experience irritability or insomnia" [23].
Some safety data are missing. EMA notes that tests on reproductive toxicity, genotoxicity and carcinogenicity are not available, that no studies have looked at driving and using machines, and that no case of overdose has been reported [21].
Interactions sources report
The clearest human data concern one liver enzyme. In a randomized crossover study, 13 healthy volunteers took a probe cocktail of medicines with and without 14 days of a commercial rhodiola product (Arctic Root, made by the Swedish Herbal Institute) [18]. Rhodiola lowered the losartan metabolite ratio by 21%, a sign of reduced CYP2C9 activity, and had no significant effect on the other enzymes tested, including CYP3A4 [18]. The authors call the effect modest but say it might be clinically relevant for CYP2C9 drugs with a narrow therapeutic index, such as phenytoin and warfarin [18]. NCCIH reports interactions with losartan [26], and Memorial Sloan Kettering advises people taking warfarin to talk to their healthcare provider [27].
In laboratory (in vitro) tests, rhodiola extracts were potent inhibitors of the enzyme CYP3A4 and the drug transporter P-glycoprotein [19]. Memorial Sloan Kettering says the clinical relevance of the CYP3A4 finding is yet to be determined [27].
Health Canada's monograph requires labels to tell people to ask a health care practitioner before use if they take antidepressant medication, hormone replacement therapy or birth control medication [23]. Memorial Sloan Kettering cites a case report of a fast, irregular heartbeat when rhodiola was taken with an antidepressant [27]. EMA's monograph, by contrast, states that no clinically relevant interactions have been observed [21]. As of November 11, 2026, we had not checked the Natural Medicines, LiverTox or DrugBank interaction entries.
If you take any of these medicines, talk to your doctor or pharmacist before combining them with rhodiola.
Regulatory status
| Market | Status | Notes |
|---|---|---|
| US | No FDA statement specific to rhodiola found as of November 11, 2026; FDA does not approve dietary supplements before sale (NCCIH). Firms are responsible for safety and labeling, and FDA can act against adulterated or misbranded products after they reach the market. | |
| UK | Rhodiola products are registered with MHRA as traditional herbal medicines (THR) for the temporary relief of symptoms associated with stress, based on traditional use only. Food supplements: not verified as of November 11, 2026; we checked MHRA's THR list and could not confirm the novel food status of rhodiola in food supplements in Great Britain. | |
| Canada | Health Canada NNHPD single-ingredient monograph (October 31, 2025) sets permitted label uses, doses (standardized extracts 144-680 mg a day, no more than 200 mg per dose) and cautions. | |
| Australia | Permissible active ingredient, only in oral medicines and only as dry root powder or its aqueous or hydroethanolic (no more than 70% ethanol) extract (Therapeutic Goods (Permissible Ingredients) Determination (No. 3) 2026). | |
| EU | EMA HMPC traditional-use monograph (Revision 1, March 20, 2024): traditional herbal medicinal product for the relief of symptoms of stress, such as fatigue and exhaustion; single dose 144-200 mg, daily dose 144-400 mg. |
FAQ
Does rhodiola help with fatigue?
Evidence is mixed. Placebo-controlled trials of one extract in night-duty physicians, students and cadets reported less mental fatigue [3][4][5], but a registered trial in nursing students on shift work found fatigue worsened compared with placebo, a result its authors say needs careful interpretation [6]. A systematic review called the research contradictory [1].
What are the side effects of rhodiola?
A review of trials reported few, mild adverse events [2]. EMA lists headache, nausea, abdominal pain, diarrhea, skin rash and itching, with frequency not known [21], and NCCIH adds dizziness, insomnia and dry mouth or excess saliva [26]. Health Canada requires labels to say to stop use with irritability or insomnia [23].
Can rhodiola interact with medicines?
In a study of 13 healthy volunteers it modestly reduced the activity of CYP2C9, an enzyme that breaks down warfarin and phenytoin [18]. Health Canada requires a label caution for people taking antidepressants, hormone replacement therapy or birth control medication [23]. If you take any of these medicines, talk to your doctor or pharmacist before combining them with rhodiola.
Is Rhodiola crenulata the same thing?
No. Rhodiola crenulata is a different species with similar traditional uses but a different chemical composition [12]. One 2026 meta-analysis pooled several Rhodiola species, including R. rosea and R. crenulata, so its results are not specific to Rhodiola rosea [12].
How long did rhodiola trials last?
Durations of the trials on this page ranged from a single dose before testing [14][15] to 42 days in a placebo-controlled trial [6] and 8 weeks in an open-label study [10]. The mean intervention length across 26 endurance trials was 33 days [11]. NCCIH describes rhodiola as possibly safe for up to 12 weeks [26].
References
- Ishaque S, Shamseer L, Bukutu C, et al. Rhodiola rosea for physical and mental fatigue: a systematic review. BMC Complement Altern Med. 2012.
- Hung SK, Perry R, Ernst E. The effectiveness and efficacy of Rhodiola rosea L.: a systematic review of randomized clinical trials. Phytomedicine. 2011.
- Darbinyan V, Kteyan A, Panossian A, et al. Rhodiola rosea in stress induced fatigue--a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty. Phytomedicine. 2000.
- Spasov AA, Wikman GK, Mandrikov VB, et al. A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen. Phytomedicine. 2000.
- Shevtsov VA, Zholus BI, Shervarly VI, et al. A randomized trial of two different doses of a SHR-5 Rhodiola rosea extract versus placebo and control of capacity for mental work. Phytomedicine. 2003.
- Punja S, Shamseer L, Olson K, et al. Rhodiola rosea for mental and physical fatigue in nursing students: a randomized controlled trial. PLoS One. 2014.
- Olsson EM, von Schéele B, Panossian AG. A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract shr-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue. Planta Med. 2009.
- Cropley M, Banks AP, Boyle J. The Effects of Rhodiola rosea L. Extract on Anxiety, Stress, Cognition and Other Mood Symptoms. Phytother Res. 2015.
- Edwards D, Heufelder A, Zimmermann A. Therapeutic effects and safety of Rhodiola rosea extract WS® 1375 in subjects with life-stress symptoms--results of an open-label study. Phytother Res. 2012.
- Lekomtseva Y, Zhukova I, Wacker A. Rhodiola rosea in Subjects with Prolonged or Chronic Fatigue Symptoms: Results of an Open-Label Clinical Trial. Complement Med Res. 2017.
- Wang X, Yang X, Gao Z, et al. The effect of Rhodiola rosea supplementation on endurance performance and related biomarkers: a systematic review and meta-analysis. Front Nutr. 2025.
- Mou J, Yin J, Fan L, et al. Antioxidant but not ergogenic or altitude-protective: a meta-analysis of Rhodiola species in healthy adults. Front Physiol. 2026.
- Sanz-Barrio PM, Noreen EE, Gilsanz-Estebaranz L, et al. Rhodiola rosea supplementation on sports performance: A systematic review of randomized controlled trials. Phytother Res. 2023.
- De Bock K, Eijnde BO, Ramaekers M, et al. Acute Rhodiola rosea intake can improve endurance exercise performance. Int J Sport Nutr Exerc Metab. 2004.
- Noreen EE, Buckley JG, Lewis SL, et al. The effects of an acute dose of Rhodiola rosea on endurance exercise performance. J Strength Cond Res. 2013.
- Walker TB, Altobelli SA, Caprihan A, et al. Failure of Rhodiola rosea to alter skeletal muscle phosphate kinetics in trained men. Metabolism. 2007.
- Jówko E, Sadowski J, Długołęcka B, et al. Effects of Rhodiola rosea supplementation on mental performance, physical capacity, and oxidative stress biomarkers in healthy men. J Sport Health Sci. 2018.
- Thu OK, Spigset O, Nilsen OG, et al. Effect of commercial Rhodiola rosea on CYP enzyme activity in humans. Eur J Clin Pharmacol. 2016.
- Hellum BH, Tosse A, Hoybakk K, et al. Potent in vitro inhibition of CYP3A4 and P-glycoprotein by Rhodiola rosea. Planta Med. 2010.
- Panossian A, Wikman G, Sarris J. Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy. Phytomedicine. 2010.
- European Medicines Agency, Committee on Herbal Medicinal Products. European Union herbal monograph on Rhodiola rosea L., rhizoma et radix (Final, Revision 1, EMA/HMPC/24177/2023). Updated March 20, 2024.
- European Medicines Agency. Rhodiolae roseae rhizoma et radix (herbal medicine overview and summary for the public). Updated May 21, 2024.
- Health Canada, Natural and Non-prescription Health Products Directorate. Rhodiola - Rhodiola rosea (NHPID single ingredient monograph). Updated October 31, 2025.
- Medicines and Healthcare products Regulatory Agency (MHRA). Herbal medicines granted a traditional herbal registration (THR), list dated October 29, 2026. Updated October 29, 2026.
- U.S. Food and Drug Administration. Dietary Supplements. Updated October 1, 2024.
- National Center for Complementary and Integrative Health (NIH). Rhodiola. 2025-04.
- Memorial Sloan Kettering Cancer Center, About Herbs. Rhodiola. Updated April 16, 2026.
- Australian Government, Department of Health, Disability and Ageing (Federal Register of Legislation). Therapeutic Goods (Permissible Ingredients) Determination (No. 3) 2026 (F2026L01382), volumes 1 and 5. Updated October 13, 2026.